Desipramine for Improving Cellular Signaling and Decreasing Symptoms of Major Depression

NCT00320632 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Depression

Interventions

DRUG: Desipramine

Sponsor

Harvard Medical School (HMS and HSDM)

Collaborators

[object Object]